SEC Form 4 · accession 0001209191-15-029928
Taxus Cardium Pharmaceuticals Group Inc. · CRXM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Murray H Hutchison
Director
Period of report
Mar 23, 2015
Accepted (ET)
Mar 27, 2015 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000772320
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to purchase Common StockF1 | $0.60 | Mar 23, 2015 | J | 50,000 | A | Mar 23, 2015 | Mar 23, 2025 | Common Stock | 50,000 | 110,000 | D |
Explanation of responses
- F1"Out-of-the-money" warrants were issued with an exercise price set at a 316% premium to the closing price of the Issuer's common stock on the issue date, for his services as a board member of the company in lieu of annual director's fees.